Lawmakers considers ending HIV funding to South Africa amid Afrikaner persecution claims
The United States is weighing a decision to end funding for HIV programmes in South Africa following allegations of persecution against Afrikaners, a move that could significantly impact one of the world’s largest HIV treatment efforts.
The potential policy shift centres on concerns raised by some US lawmakers and advocacy groups who claim that white Afrikaner minorities are facing discrimination and targeted violence. South African officials have repeatedly rejected these claims, saying crime in the country affects all groups and is not racially targeted.
The US government, through programmes such as the President’s Emergency Plan for AIDS Relief (PEPFAR), has been a major funder of South Africa’s HIV/AIDS response for two decades. Any withdrawal would threaten access to life-saving antiretroviral treatment for millions of people.
Health experts warn that cutting funding could reverse years of progress in combating HIV, potentially leading to increased infections and deaths. South Africa has the largest HIV treatment programme globally, heavily supported by international partnerships.
Pretoria has cautioned that linking health assistance to disputed political claims risks undermining public health cooperation. Analysts say the situation highlights growing tensions between foreign policy priorities and global health commitments, with vulnerable populations likely to bear the consequences if funding is reduced.
